AstraZeneca to invest $3.5 billion in the US to expand global footprint
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of.
AbbVie Inc.’s two mid-stage trials of an investigational schizophrenia drug have failed to meet its primary goal, according to a company statement.
The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency.
Johnson & Johnson has submitted regulatory applications to the US drug regulator and European Medicines Agency (EMA) for the extended approval of a blood.
US farm workers exposed to bird flu who do not show symptoms and do not wear personal protection equipment should be tested for.
The US regulator has extended a review of an application by Organon & Co.’s atopic dermatitis (eczema) drug by three months with a.
Malaria, HIV, and tuberculosis were among a list of 17 disease-causing pathogens where vaccines need to be developed as a priority to reduce.
The UK, along with a clutch of government and private entities, has set afoot plans to create the world’s first real-time surveillance system.
Britain has detected two cases of Clade Ib mpox, a variant, in household contacts of the first case, taking the total to three.
HQ Team November 3, 2024: The National Instituted of Health, US, has started a mid-stage clinical trial to examine the safety and acceptability.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com